Press release
Nuclear Medicine/Radiopharmaceuticals Market : The Development Strategies Adopted By Major Key Players And To Understand The Competitive Scenario
Nuclear Medicine/Radiopharmaceuticals Market
The Nuclear Medicine/Radiopharmaceuticals Market was worth US $5.55 billion in 2022, with a CAGR of 9%.
By 2029, the market is expected to reach US $10.14 billion.
To Know More About The Report :https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-radiopharmaceuticals-market/7741/
Report Scope: The report offers a detailed analysis of the Global Nuclear Medicine/Radiopharmaceuticals Market, including market drivers, restraints, opportunities, and challenges. It encompasses market segmentation by type, procedural volume, application, and geography. Key highlights include assessment of market dynamics, competitive outlook, and strategic business planning insights.
Research Methodology: The research methodology involves triangulation of data points from various sources and feeding them into a simulation model. Data points are obtained from paid and unpaid sources, along with paid primary interviews with key opinion leaders (KOLs). The report includes comprehensive analysis and forecast for five major geographies: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
To know about the Research Methodology :https://www.maximizemarketresearch.com/request-sample/7741
Drivers:
Increasing incidence and prevalence of cancer and cardiac ailments.
Growing adoption of modern treatments and diagnostic procedures.
Raising awareness regarding the advantages of radiopharmaceuticals.
Restraints:
High cost of nuclear medicine equipment.
Regional Insights:
North America expected to dominate the market, followed by Europe and APAC.
Well-established healthcare industry and rising awareness contribute to market growth in North America.
Presence of extensive usage of SPECT radioisotopes for diagnosis drives market growth in APAC.
Key Highlights:
Assessment of market definition, key players, and competitive outlook.
Comprehensive quantitative analysis from 2017 to 2024.
In-depth analysis of market segments, dynamics, and competition.
Detailed segmentation by type, procedural volume, application, and geography.
Forecast for five major geographies and their key regions.
To access more comprehensive information, click here:https://www.maximizemarketresearch.com/request-sample/7741
Segmentation:
by Procedures
Cardiovascular
Oncology
Central Nervous System
Skeletal
Endocrine
Gastrointestinal
Pulmonary
by Type
Therapeutic
Alpha Emitters
Beta Emitters
Brachytherapy Isotopes
Diagnostic
PET Radiopharmaceuticals
SPECT Radiopharmaceuticals
by Application
Cardiology
Oncology
Thyroid
Neurology
Others
by End-User
Research Institutes
Hospitals
Diagnostic Centers
Others
Key Players
1. Advanced Accelerator Applications S.A.
2. Iba Molecular
3. Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)
4. Eczacibasi-Monrol Nuclear Products
5. Siemens Healthcare
6. Sigma Aldrich Corporation
7. Bracco Imaging S.P.A
8. Bayer AG
9. Jubilant Pharma
10.Nordien, Inc.
11.Lantheus Medical Imaging, Inc.
12.GE Healthcare (A Fully-Owned Subsidiary of General Electric Company)
13.Mallinckrodt PLC
14.Cardinal Health, Inc.
15.Medtronic Plc.
16.Norgine B. V.
17.Curium
18.Eckert & Ziegler
19.NTP Radioisotopes
To access more comprehensive information, click here:https://www.maximizemarketresearch.com/request-sample/7741
Key Target Audience:
Research and Consulting Firms, Venture capitalists, private equity firms, and startup companies.
Radiopharmaceutical/Radioisotope Manufacturers and Distributors.
Healthcare Institutions, Contract Manufacturing Organizations (CMOs), Contract research organizations (CROs), and Government Bodies.
Market Scope: The report covers market segmentation by procedures, type, application, end-user, and geography. Key players include Advanced Accelerator Applications S.A., Iba Molecular, Nordion, Inc., Siemens Healthcare, Sigma Aldrich Corporation, and others.
Frequently Asked Questions:
Growth rate of Global Nuclear Medicine/Radiopharmaceuticals Market: CAGR of 9% during the forecast period 2023-2029.
Segments covered: Type, process, application, end-user, and region.
Key players: Advanced Accelerator Applications S.A., Iba Molecular, Nordion, Inc., Siemens Healthcare, Sigma Aldrich Corporation, and others.
Study period: 2022 to 2029.
Our Top Trending Reports
India Steam Boiler Systems Market https://www.maximizemarketresearch.com/market-report/india-steam-boiler-systems-market/46997/
Global Alzheimer's Therapeutics Market https://www.maximizemarketresearch.com/market-report/alzheimers-therapeutics-market/164747/
Aesthetic Medical Devices Market https://www.maximizemarketresearch.com/market-report/aesthetic-medical-devices-market/169746/
Hybrid Heat Pump Market https://www.maximizemarketresearch.com/market-report/hybrid-heat-pump-market/147438/
North America Battery Energy Storage System Market https://www.maximizemarketresearch.com/market-report/north-america-battery-energy-storage-system-market/6744/
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nuclear Medicine/Radiopharmaceuticals Market : The Development Strategies Adopted By Major Key Players And To Understand The Competitive Scenario here
News-ID: 3374962 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Power Semiconductor Market to Reach USD 51.83 Billion by 2030 at 3.18% CAGR - Po …
According to a new report by Maximize Market Research, the global power semiconductor market was valued at USD 41.63 billion in 2023 and is projected to reach USD 51.83 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.18% over the forecast period 2024-2030.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/28191/
♦ Key Highlights
Market Size & CAGR: USD 41.63 Bn in 2023, expected to reach USD 51.83 Bn by…
Microneedle Drug Delivery Systems Market Set to Reach US $ 9.46 Billion by 2030 …
According to a new report by Maximize Market Research, the global microneedle drug delivery systems market was valued at roughly US $ 6.11 billion in 2024 and is projected to reach approximately US $ 9.46 billion by 2030, growing at a compound annual growth rate (CAGR) of around 7.7%.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/215694/
♦ Key Highlights
Market size & CAGR: Estimated at ~US $ 6.11 billion in 2024, forecast to…
Automotive Paints Market Forecast to Reach USD 15.77 Billion by 2030 at 4.7 % CA …
According to a new report by Maximize Market Research, the global automotive paints market was valued at USD 10.85 billion in 2023 and is projected to reach USD 15.77 billion by 2030, growing at a CAGR of approximately 4.7 % during 2024-2030. The forecast covers global coatings used in vehicle manufacturing and refinish applications, with a focus on key regions such as Asia-Pacific, North America and Europe.
► Get a sample…
Petrochemicals Market Set to Reach USD 1,122.31 Billion by 2032 at a CAGR of 6.5 …
According to a new report by Maximize Market Research, the global petrochemicals market was valued at USD 678.13 billion in 2024 and is projected to reach USD 1,122.31 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032. The growth is anchored in expanding demand across automotive, electronics, construction, and packaging industries.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/126575/
♦ Key Highlights
Market size + CAGR:…
More Releases for Radiopharmaceuticals
Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to…
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842
This latest report researches the industry structure, sales, revenue, price and…
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…
